Governance Novartis AG

NOVN

CH0012005267

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 11:30:18 2024-12-12 am EST			5-day change	1st Jan Change
88.06 ^CHF	+0.14%		-2.57%	+3.76%

03:00pm	Unsupported price hikes added $815 million to US drug spending in 2023	RE
Dec. 11	Monte Rosa Closes Global License Agreement With Novartis	MT

Executive Committee: Novartis AG

Manager

Positions heldSince

Vasant Narasimhan

48 year

Chief Executive Officer

2018-01-31

Karen Hale

56 year

General Counsel

2021-05-14

Kees Roks

61 year

Comptroller/Controller/Auditor

2022-04-30

Shreeram Aradhye

62 year

Chief Tech/Sci/R&D Officer

2022-05-15

Robert Kowalski

56 year

Human Resources Officer

2021-08-31

Charlotte Pamer-Wieser

Corporate Secretary

2011-08-31

Klaus Moosmayer

56 year

Compliance Officer

2018-11-30

Steffen Lang

57 year

Chief Operating Officer

2022-04-03

Harry Werner Kirsch

59 year

Director of Finance/CFO

2013-04-23

Composition of the Board of Directors: Novartis AG

Director

CommitteesSince

Hans Jörg Reinhardt

68 year

Compensation Committee	2018-04-19
Governance Committee	2017-04-20
Nominating Committee	2017-04-20

Bridgette Heller

62 year

Compensation Committee Chair	2019-09-12
Audit Committee	2021-06-28
Compensation Committee	2020-02-27
Governance Committee	2021-02-01
Nominating Committee	2021-02-01
Finance Committee

Patrice Bula

68 year

Compensation Committee	2019-02-27
Governance Committee Chair	2019-02-27
Nominating Committee Chair	2019-02-27

Simon Moroney

65 year

Compensation Committee Chair	2020-02-27
Compensation Committee	2021-03-31
Nominating Committee	2021-03-31

Ana de Pro Gonzalo

57 year

Audit Committee	2022-03-03
Compensation Committee	2021-12-03
Audit Committee Chair	2020-05-31

Daniel Hochstrasser

64 year

Audit Committee	2022-03-03
Governance Committee	2022-03-03
Nominating Committee	2022-03-03

John Young

60 year

Audit Committee
Governance Committee
Compensation Committee	2022-08-17

Frans van Houten

64 year

Audit Committee	2023-06-01
Governance Committee Chair	2023-06-01
Nominating Committee Chair	2023-06-01

Bill Winters

63 year

Compensation Committee	2012-12-31
Governance Committee	2019-02-27
Nominating Committee	2019-02-27

Charles Sawyers

65 year

Governance Committee	2012-12-31
Nominating Committee	2012-12-31

Nancy Andrews

65 year

Governance Committee	2020-02-27
Nominating Committee	2020-02-27

Liz Doherty

67 year

Audit Committee Chair

2019-05-09

Ton Büchner

59 year

Audit Committee

2018-03-01

Latest Appointments: Novartis AG

Maeve Waldron-Lynch to Join Tango Therapeutics, Inc. as Senior Vice President, Head of Clinical Development	Nov. 06	CI
NovoCure Limited Appoints Christoph Brackmann as Senior Financial Advisor	Oct. 30	CI
NovoCure Limited Announces CFO Appointment	Oct. 30	CI
Incannex Healthcare Inc. Announces Appointment of Dr. Lou Barbato as Chief Medical Officer	Oct. 24	CI
Kyverna Therapeutics, Inc. Announces CEO Changes	Sep. 16	CI
EXECUTIVE CHANGES: Invinity replaces CEO; Gulf Keystone chair dies	Sep. 06	AN
EDX Medical Group Names New Chief Commercial Officer	Sep. 05	MT

More news

Former Officers and Directors: Novartis AG

Insider

Positions held

SinceUntil

Srikant T. Madhav Datar

Director/Board Member	2002-12-31	2020-12-31
Independent Dir/Board Member	2002-12-31	2020-12-31

Pierre Landolt

Director/Board Member	2010-01-07	2018-03-01
Independent Dir/Board Member	2010-01-07	2018-03-01
Corporate Officer/Principal	1995-12-31	2010-01-07

Joseph Jimenez

Director/Board Member	2009-11-01	2010-01-07
Chief Executive Officer	2010-01-31	2017-12-31
Corporate Officer/Principal	2010-01-07	2010-01-25

Jürgen Brokatzky-Geiger

Human Resources Officer	2004-12-31	2014-03-05
Corporate Officer/Principal	2014-03-05	2017-09-30

Wendelin Wiedeking

Director/Board Member	2002-12-31	2014-02-24
Independent Dir/Board Member	2002-12-31	2014-02-24
Corporate Officer/Principal	2002-12-31	2010-01-07

Rolf M. Zinkernagel

Director/Board Member	2010-01-07	2014-02-24
Independent Dir/Board Member	1998-12-31	2014-02-24
Corporate Officer/Principal	1998-12-31	2010-01-07

Alexandre F. Jetzer-Chung

Director/Board Member	2010-01-07	2011-02-21
Corporate Officer/Principal	1995-12-31	2010-01-07

Raymund Breu

Director of Finance/CFO

1996-11-30

2008-12-31

William Brody

Director/Board Member	2009-02-23	-
Independent Dir/Board Member	2011-08-24	-

Urs Bärlocher

General Counsel

1998-12-31

2007-08-30

Thomas Ebeling

Corporate Officer/Principal

1999-12-31

2006-12-31

Pierre F. Dodion

Sales & Marketing

2001-12-31

2005-12-31

Karen Hübscher

Public Communications Contact

1999-12-31

2005-12-31

Andreas von Planta

Director/Board Member	2005-12-31	-
Independent Dir/Board Member	2005-12-31	-

François Martelet

Corporate Officer/Principal

2003-06-30

2005-06-30

Ian Garland

Corporate Officer/Principal

2005-05-31

Joachim P. H. Schupp

Corporate Officer/Principal

1984-12-31

2004-09-30

Ronen Tamir

Investor Relations Contact	2011-10-27	-
Public Communications Contact	2011-10-27	-
Corporate Officer/Principal	2003-12-31	2011-10-27

Marshall E. Reese

Corporate Officer/Principal

1998-12-31

2003-12-31

Gilbert Wenzel

Corporate Officer/Principal

2000-10-31

2002-12-31

Mihael Polymeropoulos

Corporate Officer/Principal

1997-12-31

2002-12-31

Paul Herrling

Chief Tech/Sci/R&D Officer

2002-10-31

Bruce F. Fleming

Corporate Officer/Principal

2001-05-31

2002-05-31

Silke Zentner

Public Communications Contact

2002-04-04

Fredrik Ollila

Corporate Officer/Principal

2001-12-31

Paolo Baroldi

Corporate Officer/Principal

1997-12-31

2001-12-31

James New

Corporate Officer/Principal

1998-12-31

Birgit Breuel

Corporate Officer/Principal

1995-12-31

Peter Burckhardt

Director/Board Member	2009-12-30	-
Corporate Officer/Principal	1995-12-31	2009-12-30

Norman Hardman

Chief Tech/Sci/R&D Officer

1995-12-31

Helmut Sihler

Director/Board Member

1995-12-31

John McKenna

Corporate Officer/Principal

1989-12-31

Ann Bailey

Public Communications Contact

1981-12-31

Malcolm B. Cheetham

Comptroller/Controller/Auditor

Bobby Singh

Corporate Officer/Principal

Rob Goshert

Corporate Officer/Principal

David Metzger

Corporate Officer/Principal

Christoph Hüls

Corporate Officer/Principal

Jeffrey Hrkach

Corporate Officer/Principal

Peter Herold

Corporate Officer/Principal

Ruth Metzler-Arnold

Public Communications Contact

2009-07-27

Hans-Georg Capraro

Corporate Officer/Principal

William P. Keane

Corporate Officer/Principal

Cees Winnips

Corporate Officer/Principal

Adrian Hunter

Corporate Officer/Principal

Maike July-Grolman

Corporate Officer/Principal

Dominique Cheneval

Corporate Officer/Principal

Eric Wayne Evans

Director of Finance/CFO

Siv Lindbratt Börjes

Corporate Officer/Principal

MaryAnn DeMarco

Corporate Officer/Principal

Gabor Veres

Corporate Officer/Principal

Michael Horne

Corporate Officer/Principal

John McAdoo

Corporate Officer/Principal

James Phillips

Corporate Officer/Principal

Virginia Jamieson

Corporate Officer/Principal

John H. van Duzer

Corporate Officer/Principal

Stuart J. Davie

Chief Tech/Sci/R&D Officer

Ian Stuart Charles Talmage

Corporate Officer/Principal

Roland M. Jeannet

Corporate Officer/Principal

William J. Rutter

Director/Board Member

Armin M. Kessler

Sales & Marketing

Günter Frankenne

Director/Board Member

Jeret Bode

Corporate Officer/Principal

Peter E. Carlin

Corporate Officer/Principal

Nagesh Mahanthappa

Corporate Officer/Principal

Phil Johnson

Corporate Officer/Principal

Ingrid Duplain

Corporate Secretary

Bruno Heynen

Corporate Secretary

Corinne Hoff

Public Communications Contact

Randall S. Moore

Corporate Officer/Principal

Geert C. Mudde

Corporate Officer/Principal

Geoff MacKay

Corporate Officer/Principal

Max Burger

Chairman	2010-04-20	-
President	2009-07-16	2010-04-20

Peter Thomas Sany

Chief Tech/Sci/R&D Officer

Ian Matthews

Corporate Officer/Principal

John Slevin

Corporate Officer/Principal

Gordon Wright

Corporate Officer/Principal

Jutta Monika Heim

Corporate Officer/Principal

Karel Petrak

Corporate Officer/Principal

Ann Moravick

Corporate Officer/Principal

Thomas Littke

Corporate Officer/Principal

Terry Hart

Corporate Officer/Principal

Humphrey Harte

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	25
Female	6

Of which Executive Committee

Male	8
Female	1

Of which Directors

Male	10
Female	3

ESG Refinitiv

B-

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).

Employees

76,057

Sector

Pharmaceuticals

Calendar

06:30pm - San Antonio Breast Cancer Symposium - Abstract Number - P2-12-02

More about the company